<document xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:z="http://www.ebi.ac.uk/z" source="Whatizit"><text><SENT sid="0" pm="."><plain>Anticardiolipin antibody (aCL) is considered to be one of the contributory factors in the development of <z:hpo ids='HP_0011009'>acute</z:hpo> <z:hpo ids='HP_0002140'>ischemic stroke</z:hpo> </plain></SENT>
<SENT sid="1" pm="."><plain><z:hpo ids='HP_0011010'>Chronic</z:hpo> <z:hpo ids='HP_0012115'>hepatitis</z:hpo> C <z:e sem="disease" ids="C0042769" disease_type="Disease or Syndrome" abbrv="">virus infection</z:e> (HCV) and the <z:e sem="disease" ids="C0085278" disease_type="Disease or Syndrome" abbrv="">antiphospholipid syndrome</z:e> are two conditions that have increased the risk of <z:hpo ids='HP_0001297'>stroke</z:hpo> </plain></SENT>
<SENT sid="2" pm="."><plain>The purpose of this study was to investigate the prevalence of anticardiolipin antibodies in patients with asymptomatic <z:hpo ids='HP_0011010'>chronic</z:hpo> <z:hpo ids='HP_0012115'>hepatitis</z:hpo> C <z:e sem="disease" ids="C0042769" disease_type="Disease or Syndrome" abbrv="">virus infection</z:e>-related <z:hpo ids='HP_0011009'>acute</z:hpo> <z:hpo ids='HP_0002140'>ischemic stroke</z:hpo> </plain></SENT>
<SENT sid="3" pm="."><plain>Fifty eight patients (39 women, 19 men), mean age 62 years (range 46-77 years) with <z:hpo ids='HP_0011009'>acute</z:hpo> <z:hpo ids='HP_0002140'>ischemic stroke</z:hpo> and asymptomatic <z:hpo ids='HP_0011010'>chronic</z:hpo> <z:hpo ids='HP_0012115'>hepatitis</z:hpo> C <z:e sem="disease" ids="C0042769" disease_type="Disease or Syndrome" abbrv="">virus infection</z:e> were studied; <z:hpo ids='HP_0000001'>all</z:hpo> were positive for anti-HCV antibodies </plain></SENT>
<SENT sid="4" pm="."><plain>A control group of 36 patients (20 women, 16 men), mean age 58 years (range 44-75 years) with <z:hpo ids='HP_0002140'>ischemic stroke</z:hpo> without HCV were also tested </plain></SENT>
<SENT sid="5" pm="."><plain>Both anti-HCV antibodies and IgG aCL antibodies were measured by enzyme-linked immunosorbent assay (ELISA) </plain></SENT>
<SENT sid="6" pm="."><plain>The significantly higher levels of IgG aCL antibodies were detected in serum samples of 27/58 (46%) patients with <z:hpo ids='HP_0011009'>acute</z:hpo> <z:hpo ids='HP_0002140'>ischemic stroke</z:hpo> and asymptomatic <z:hpo ids='HP_0011010'>chronic</z:hpo> <z:hpo ids='HP_0012115'>hepatitis</z:hpo> C <z:e sem="disease" ids="C0042769" disease_type="Disease or Syndrome" abbrv="">virus infection</z:e> </plain></SENT>
<SENT sid="7" pm="."><plain>The control group had much lower levels of IgG aCL antibodies in 2/36 (5%) patients </plain></SENT>
<SENT sid="8" pm="."><plain>This study clearly shows a high prevalence of IgG aCL antibodies in the serum of patients with <z:hpo ids='HP_0011009'>acute</z:hpo> <z:hpo ids='HP_0002140'>ischemic stroke</z:hpo> and HCV </plain></SENT>
<SENT sid="9" pm="."><plain>Mean levels of serum IgG aCL antibodies were significantly higher among the HCV patients with <z:hpo ids='HP_0011009'>acute</z:hpo> <z:hpo ids='HP_0002140'>ischemic stroke</z:hpo> than the patients with <z:hpo ids='HP_0011009'>acute</z:hpo> <z:hpo ids='HP_0002140'>ischemic stroke</z:hpo> without HCV (94.8+/-7.6 GPL U/mL as compared to 27.2+/-3.2 GPL U/mL), p&lt;0.001 </plain></SENT>
<SENT sid="10" pm="."><plain>We showed that a number of <z:hpo ids='HP_0011010'>chronic</z:hpo> <z:hpo ids='HP_0012115'>hepatitis</z:hpo> C <z:e sem="disease" ids="C0042769" disease_type="Disease or Syndrome" abbrv="">virus infection</z:e>-related <z:hpo ids='HP_0002140'>ischemic strokes</z:hpo> is associated with the presence of anticardiolipin antibodies, a condition predisposing to <z:hpo ids='HP_0003256'>coagulopathy</z:hpo> </plain></SENT>
<SENT sid="11" pm="."><plain>These results suggest that anticardiolipin antibodies associated with HCV may be an important marker for <z:hpo ids='HP_0011009'>acute</z:hpo> <z:hpo ids='HP_0002140'>ischemic stroke</z:hpo> </plain></SENT>
<SENT sid="12" pm="."><plain>The higher prevalence and titre of IgG aCL antibodies in patients with HCV suggests that these humoral factors might be involved in the pathogenesis of <z:hpo ids='HP_0002140'>ischemic stroke</z:hpo> </plain></SENT>
</text></document>